GE HealthCare’s commitment to advancing precision care in cardiology through innovative molecular imaging solutions is on ...

FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.

MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for development under strategic partnership with Orano MedPromising tumor ...

(UroToday.com) The 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting held in New Orleans, LA, was host to a session on non-beta emitter PSMA radioligand therapy. Dr.

The peacock chair, also known as the rattan throne, has seated presidents and prisoners, moms-to-be and musicians. A staple ...

Telix’s Illuccix PSMA-PET imaging agent receives German approval: Melbourne, Australia Monday, June 9, 2025, 14:00 Hrs [IST] Telix announces that its prostate cancer PET imaging ...

Illuccix, after radiolabelling with gallium-68, is indicated in Greece for the detection of prostate-specific membrane ...

Illuccix, after radiolabelling with gallium-68, is indicated in Germany for the detection of prostate-specific membrane ...

In the US, patients diagnosed with noninfectious uveitis (NIU) are higher in number than infectious uveitis (IU). In 2022, ...

Pulsar UK has signed an agreement with Thales Alenia Space (TAS) for the Pulsar’s 5kW MOONRANGER Hall-effect thrusters, which ...